bf/NASDAQ:SANA_icon.jpeg

COM:SANA

Sana Biotechnology, Inc.

  • Stock

Last Close

2.53

21/11 21:00

Market Cap

1.15B

Beta: -

Volume Today

1.36M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-130.78M
-
-285.31M
118.16%
-355.93M
24.75%
-269.48M
24.29%
-283.25M
5.11%
depreciation and amortization
1.83M
-
5.92M
224.26%
11.07M
86.96%
15.63M
41.15%
30.86M
97.54%
deferred income tax
-7.55M
-
-96.24M
-
stock based compensation
1.50M
-
5.83M
289.31%
22.36M
283.70%
38.34M
71.44%
35.53M
7.31%
change in working capital
10.53M
-
6.16M
41.52%
9.80M
59.21%
7.54M
23.05%
18.61M
146.76%
accounts receivables
inventory
accounts payables
-421K
-
1.98M
570.78%
-266K
113.42%
1.06M
497.74%
1.03M
2.93%
other working capital
10.95M
-
4.17M
61.87%
10.07M
141.18%
6.48M
35.59%
17.58M
171.19%
other non cash items
38.97M
-
129.42M
232.08%
61.64M
52.37%
-82.08M
233.15%
40.90M
149.83%
net cash provided by operating activities
-85.50M
-
-137.98M
61.37%
-251.05M
81.95%
-290.05M
15.53%
-253.58M
12.57%
investments in property plant and equipment
-26.18M
-
-23.87M
8.83%
-29.86M
25.09%
-20.88M
30.09%
-20.03M
4.04%
acquisitions net
-3.19M
-
228.69K
107.16%
-231.44K
-
purchases of investments
-141.52M
-
-387.43M
173.77%
-491.39M
26.83%
-78.69M
83.99%
-157.74M
100.47%
sales maturities of investments
82.98M
-
158.74M
91.31%
280.02M
76.40%
310.13M
10.75%
349.79M
12.79%
other investing activites
59K
-
-228.69K
487.61%
-4.57M
1,900.08%
231.44K
105.06%
net cash used for investing activites
-87.86M
-
-252.56M
187.46%
-245.80M
2.68%
210.56M
185.66%
172.01M
18.31%
debt repayment
common stock issued
1K
-
149K
14,800%
626.40M
420,306.04%
601K
99.90%
31.65M
5,165.56%
common stock repurchased
dividends paid
other financing activites
223.72M
-
435.54M
94.68%
5.35M
98.77%
4.31M
19.34%
net cash used provided by financing activities
223.73M
-
435.69M
94.74%
631.75M
45.00%
4.91M
99.22%
31.65M
544.13%
effect of forex changes on cash
4.41M
-
net change in cash
50.36M
-
45.14M
10.36%
134.90M
198.83%
-74.58M
155.28%
-45.52M
38.97%
cash at beginning of period
31.45M
-
81.81M
160.15%
126.95M
55.18%
261.85M
106.26%
182.87M
30.16%
cash at end of period
81.81M
-
126.95M
55.18%
261.85M
106.26%
187.27M
28.48%
137.35M
26.66%
operating cash flow
-85.50M
-
-137.98M
61.37%
-251.05M
81.95%
-290.05M
15.53%
-253.58M
12.57%
capital expenditure
-26.18M
-
-23.87M
8.83%
-29.86M
25.09%
-20.88M
30.09%
-20.03M
4.04%
free cash flow
-111.69M
-
-161.85M
44.92%
-280.92M
73.56%
-310.93M
10.68%
-273.61M
12.00%

All numbers in (except ratios and percentages)